Clinical Trial: Study of BMS-986453 in Newly Diagnosed Multiple Myeloma

U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07333261) titled 'Study of BMS-986453 in Newly Diagnosed Multiple Myeloma' on Dec. 02, 2025.

Brief Summary: This is a phase 1b study evaluating if BMS-986453 is safe and effective in treating people who have newly diagnosed multiple myeloma after completing initial therapy (induction) when a stem cell transplant is not intended.

Study Start Date: Jan., 2026

Study Type: INTERVENTIONAL

Condition: Multiple Myeloma

Intervention: DRUG: BMS-986453

Will be given as a single dose administered by IV infusion.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Susan Bal

Information provided by (Responsible Party): Susan Bal, University of Alabama at Bir...